Company Description
Genesis Research and Development Corporation Limited. The Group's principal activities are the research, discovery and development of novel drugs as diverse as therapeutic vaccines for immune disorders such as psoriasis, asthma and eczema; vaccines ...
More
Breaking News
Forbes.com - October 10, 2008 3:35 PM
Vyteris, Inc. (OTCBB: VYTR), developer and manufacturer of the first FDA-approved active patch transdermal drug delivery system (LidoSite(R)) and a leader in active transdermal drug delivery technology, announced the establishment of its Business ...
Reuters - October 10, 2008 3:25 PM
Business Development Professionals to Team-up on Pursuit of Licensing and Partnership Opportunities FAIR LAWN, N.J.--(Business Wire)-- Vyteris, Inc. (OTCBB: VYTR), developer and manufacturer of the first FDA-approved active patch transdermal drug ...
Wired News - September 27, 2008 6:50 PM
The thrilling season premiere of Terminator: The Cryptic and chilly ZeiraCorp CEO Catherine Weaver, a character introduced in Monday's season two premiere, isn't exactly what she seems. In addition to controlling a high-tech research and development ...
Forbes.com - September 20, 2008 9:19 PM
LAIYANG, China, Sept. 4 /Xinhua-PRNewswire-FirstCall/ -- Genesis Pharmaceuticals Enterprises, Inc. (OTC Bulletin Board: GNPH) ('Genesis' or the 'Company'), a leading pharmaceutical company in the People's Republic of China, today announced that it ...
International Herald Tribune - September 16, 2008 11:14 AM
Longtime Middlebury College economics professor Michael Claudon should have been ecstatic. More and more students at the quintessential Vermont liberal arts school â?? nearly 1 in 6 â?? had picked his department as a major. But Claudon could tell many ...
